People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Pharmaceuticals, Biotechnology, Healthtech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Allena Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $80.5M | $75.1M | 2014 |
| Alcresta Therapeutics, Inc. | — | Biotechnology | Series C | $75.9M | $409.6M | 2017 |
| Health Essentials Holdings, Inc. | — | Healthtech | Series C | $61.9M | $31.5M | 2012 |
| Artemis Health Inc. | — | Healthtech | Series B | $46.4M | $566.7M | 2019 |
| DocuTAP, Inc. | — | Other | Series A | $28.6M | $90.8M | 2014 |
| Mural Health Technologies, Inc. | — | Healthtech | Series A | $20.2M | $69.6M | 2024 |
| Stromedix Inc | — | Pharmaceuticals | Seed | $2.0M | $76.1M | 2011 |
Stephen Kraus at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Kraus on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Topper | 2 | 12 |
| Alexey Margolin | 2 | 3 |
| Peter Barrett | 1 | 18 |
| Garheng Kong | 1 | 16 |
| Dalton Wright | 1 | 10 |
| Jon Lim | 1 | 9 |
| Robert Tepper | 1 | 7 |
| Daniel Lynch | 1 | 7 |
| Axel Bolte | 1 | 6 |
| Steve Kraus | 1 | 6 |
| Ambar Bhattacharyya | 1 | 6 |
| Michael Gilman | 1 | 6 |
| Darren Black | 1 | 6 |
| Gino Santini | 1 | 5 |
| Grant Gordon | 1 | 5 |
| Thomas Flynn | 1 | 4 |
| Kevin Lynch | 1 | 4 |
| Daniel Tasse | 1 | 4 |
| Todd Creech | 1 | 4 |
| Ashok Subramanian | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.